Groen HJM - Search Results

1

⁸⁹Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.

Bensch F, van der Veen EL, Lub-de Hooge MN, Jorritsma-Smit A, Boellaard R, Kok IC, Oosting SF, Schröder CP, Hiltermann TJN, van der Wekken AJ, Groen HJM, Kwee TC, Elias SG, Gietema JA, Bohorquez SS, de Crespigny A, Williams SP, Mancao C, Brouwers AH, Fine BM, de Vries EGE. Bensch F, et al. Among authors: groen hjm. Nat Med. 2018 Dec;24(12):1852-1858. doi: 10.1038/s41591-018-0255-8. Epub 2018 Nov 26. Nat Med. 2018. PMID: 30478423 Clinical Trial.

2

Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study.

Groen HJ, van der Leest AH, de Vries EG, Uges DR, Szabó BG, Mulder NH. Groen HJ, et al. Br J Cancer. 1995 Oct;72(4):992-7. doi: 10.1038/bjc.1995.448. Br J Cancer. 1995. PMID: 7547255 Free PMC article. Clinical Trial.

3

Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study.

van Gameren MM, Willemse PH, Mulder NH, Limburg PC, Groen HJ, Vellenga E, de Vries EG. van Gameren MM, et al. Blood. 1994 Sep 1;84(5):1434-41. Blood. 1994. PMID: 8068939 Free article. Clinical Trial.

4

Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.

Groen HJ, Sleijfer S, Meijer C, Kampinga HH, Konings AW, De Vries EG, Mulder NH. Groen HJ, et al. Br J Cancer. 1995 Dec;72(6):1406-11. doi: 10.1038/bjc.1995.522. Br J Cancer. 1995. PMID: 8519652 Free PMC article.

5

Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatin.

Groen HJ, van der Mark TW, van der Leest AH, de Vries EG, Mulder NH. Groen HJ, et al. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2044-8. doi: 10.1164/ajrccm.152.6.8520774. Am J Respir Crit Care Med. 1995. PMID: 8520774

6

Red blood cell glutathione levels in lung cancer patients treated by radiation and continuously infused carboplatin.

Groen HJ, Meijer C, De Vries EG, Mulder NH. Groen HJ, et al. Anticancer Res. 1996 Mar-Apr;16(2):1033-7. Anticancer Res. 1996. PMID: 8687095

7

Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell lines.

Bakker M, Renes J, Groenhuijzen A, Visser P, Timmer-Bosscha H, Müller M, Groen HJ, Smit EF, de Vries EG. Bakker M, et al. Int J Cancer. 1997 Nov 4;73(3):362-6. doi: 10.1002/(sici)1097-0215(19971104)73:3<362::aid-ijc10>3.0.co;2-f. Int J Cancer. 1997. PMID: 9359483

8

Approaches to lung cancer treatment using the CD3 x EGP-2-directed bispecific monoclonal antibody BIS-1.

Kroesen BJ, Nieken J, Sleijfer DT, Molema G, de Vries EG, Groen HJ, Helfrich W, The TH, Mulder NH, de Leij L. Kroesen BJ, et al. Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):203-6. doi: 10.1007/s002620050433. Cancer Immunol Immunother. 1997. PMID: 9435874 Free PMC article. Clinical Trial.

9

Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients.

Bakker M, Droz JP, Hanauske AR, Verweij J, van Oosterom AT, Groen HJ, Pacciarini MA, Domenigoni L, van Weissenbruch F, Pianezzola E, de Vries EG. Bakker M, et al. Br J Cancer. 1998;77(1):139-46. doi: 10.1038/bjc.1998.22. Br J Cancer. 1998. PMID: 9459159 Free PMC article. Clinical Trial.

10

Effects of gemcitabine on renal function in patients with non-small cell lung cancer.

Gietema JA, Groen HJ, Meijer S, Smit EF. Gietema JA, et al. Eur J Cancer. 1998 Jan;34(1):199-202. doi: 10.1016/s0959-8049(97)00354-7. Eur J Cancer. 1998. PMID: 9624259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters